Impact of referral for gastro-oesophageal reflux disease on the workload of an academic Gastroenterology Unit

Digestive and Liver Disease

Volumn 37, Issue 10, 2005, Pages 735-740

  Cantu P ^a   Savojardo, D ^a   Carmagnola, S ^a   Penagini, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Gastro oesophageal reflux disease; Oesophageal manometry; Oesophagitis; pH monitoring

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONSULTATION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FREQUENCY ANALYSIS; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PREVALENCE; PROFESSIONAL PRACTICE; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; TREATMENT INDICATION; WORKLOAD; ESOPHAGEAL PH MONITORING; HOSPITAL SUBDIVISIONS AND COMPONENTS; INCIDENCE; MANOMETRY; PATHOLOGY; STATISTICS; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL PH MONITORING; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HOSPITAL UNITS; HUMANS; INCIDENCE; ITALY; MANOMETRY; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; WORKLOAD;

EID: 33744733783     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.04.025     Document Type: Article

References (45)

1. Locke III G.R., Talley N.J., Fett S.L., Zinsmeister A.R., and Melton III L.J. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
2. Louis E., DeLooze D., Deprez P., Hiele M., Urbain D., Pelckmans P., et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 14 (2002) 279-284
3. Levin T.R., Schmittdiel J.A., Kunz K., Henning J.M., Henke C.J., Colby C.J., et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 103 (1997) 520-528
4. Ofman J.J. The economic and quality of life impact of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 98 Suppl. (2003) 8-14
5. Sandler R.S., Everhart J.E., Donowits M., Adams E., Cronin K., Goodman C., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
6. Wahlqvist P., Carlsson J., Stalhammar N.O., and Wiklund I. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-oesophageal reflux disease (WPAI-GERD)-results from a cross-sectional study. Value Health 5 (2002) 106-113
7. Lieberman D.A., De Garmo P.L., Fleischer D.E., Eisen G.M., and Helfand M. Patterns of endoscopy use in the United States. Gastroenterology 118 (2000) 619-624
8. Russo M.W., Wei J.T., Thiny M.T., Gangarosa L.M., Brown A., Ringel Y., et al. Digestive and liver diseases statistics. Gastroenterology 126 (2004) 1448-1453
9. Savary M, Miller G. The esophagus: handbook and atlas of endoscopy. Solothrun, Switzerland: Verlag Gassmann; 1978. p. 119-59.
10. Sharma P., McQuaid K., Dent J., Fennerty M.B., Sampliner R., Spechler S., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 127 (2004) 310-330
11. Marshall B.J., Goodwin C.S., Warren J.R., Murray R., Blincow E.D., Blackbourn S.J., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2 (1988) 1437-1442
12. Kahrilas P.J., Clouse R.E., and Hogan W.J. An American Gastroenterological Association medical position statement on the clinical use of esophageal manometry. Gastroenterology 107 (1994) 1865-1884
13. Kahrilas P.J., and Quigley E.M.M. American gastroenterological association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology 110 (1996) 1981-1996
14. Colombo P., Mangano M., Bianchi P.A., and Penagini R. Effect of calories and fat on postprandial gastro-oesophageal reflux. Scand J Gastroenterol 1 (2002) 3-5
15. Penagini R., Cantù P., Mangano M., Colombo P., and Bianchi P.A. Long-term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia. Scand J Gastroenterol 4 (2002) 380-384
16. Winters C., Spurling T.J., Chobanian S.J., Curtis D.J., Esposito R.L., Hacker III J.F., et al. Barrett's esofagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92 (1987) 118-124
17. Venables T.L., Newland R.D., Patel A.C., Hole J., Wilcock C., and Turbitt M.L. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 32 (1997) 965-973
18. Carlsson R., Dent J., Watts R., Riley S., Sheikh R., Hatlebakk J., et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 10 (1998) 119-124
19. Martinez S.D., Malagon I.B., Garwal H.S., Cui H., and Fass R. Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Aliment Pharmacol Ther 17 (2003) 537-545
20. Talley N.J., Silverstein M.D., Agreus L., Nyren O., Sonnenberg A., and Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 114 (1998) 582-595
21. Canga III C., and Vakil N. Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy. Am J Gastroenterol 97 (2002) 600-603
22. British Society of Gastroenterology. Dyspepsia management guidelines. London: The Society; 1996. Available from url: http://www.bsg.org.uk/clinical_prac/guidelines/dyspepsia.htm.
23. Scottish Intercollegiate Guidelines Network. Dyspepsia. A national clinical guidelines. SIGN 2003; publication no. 68. Available from url: http://www.sign.ac.uk.
24. Rossi A., Bersani G., Ricci G., DeFabritiis G., Pollino V., Suzzi A., et al. ASGE guidelines for the appropriate use of upper endoscopy: association with endoscopic findings. Gastrointest Endosc 56 (2002) 714-719
25. Notiziario GISMAD. Il progresso medico. Lombardo editors. Rome. 1994;50:1-20.
26. Loof L., Gotell P., and Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 28 (1993) 113-118
27. Ronkainen J.A., Aro P., Storskrubb T., Vieth M., Lind T., Graffner H., et al. Prevalence of esophagitis and endoscopy-negative reflux disease in a population. A report from the Kalixanda study. Gastroenterology 122 (2002) A213
28. Maurizio Zagari R., Martuzzi C., Fuccio L., Ricciardiello L., Maltoni S., Di Marco M., et al. Epidemiology of gastro-oesophageal reflux disease symptoms and endoscopic findings in the general population. Dig Liver Dis 36 Suppl. 2 (2004) S179
29. Quigley E.M.M. Gastro-oesophageal reflux disease-spectrum or continuum?. Q J Med 90 (1997) 75-78
30. Lagergren J., Bergstrom R., Lindgren A., and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Eng J Med 340 (1999) 825-831
31. Pace F., and Bianchi Porro G. Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Am J Gastreonterol 99 (2004) 946-949
32. Fass R., and Ofman J.J. Gastroesophageal reflux disease-should we adopt a new conceptual framework?. Am J Gastroenterol 97 (2002) 1901-1909
33. Fitzgerald R.C., Onwuegbusi B.A., Bajaj-Elliott M., Saeed I.T., Burnham W.R., and Farthing M.J.G. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 50 (2002) 451-459
34. Bonelli L. Barrett's esophagus: results of a multicentric survey. Endoscopy 25 Suppl. (1993) 652-654
35. Cameron A.J., and Lomboy C.T. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103 (1992) 1241-1245
36. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002 (2002) 461-467
37. Rex D.K., Cummings O.W., Shaw M., Cumings M.D., Wong R.K.H., Vasudeva R.S., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
38. Harvey R.F., Salih S.Y., and Read A.E. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1 (1983) 632-634
39. Laine L., Ahnen D., McClain C., Solcia E., and Walsh J.H. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 14 (2000) 651-668
40. Bateman D.N., Colin-Jones D., Hartz S., Langman M., Logan R.F., Mant J., et al. Mortality study of 18000 patients treated with omeprazole. Gut 52 (2003) 942-946
41. Sonnenberg A., Delcò F., and El-Serag H.B. Empirical therapy versus diagnostic tests in gastroesophageal reflux disease. A medical decision analysis. Dig Dis Sci 43 (1998) 1001-1008
42. Kahrilas P.J. Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 98 Suppl. (2003) S15-S23
43. Fass R., Fennerty M.B., Ofman J.J., Gralnek I.M., Johnson C., Camargo E., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 115 (1998) 42-49
44. O'Connor J.F.B., Singer M.E., and Richter J.E. The cost-effectiveness of strategies to assess gastroesophageal reflux as an exacerbating factor in asthma. Am J Gastroenterol 94 (1999) 1472-1480
45. Vinjirayer E., Gonzales B., Brensinger C., Bracy N., Obelmejias R., Katzka D.A., et al. Ineffective motility is not a marker for gastroesophageal reflux disease. Am J Gastroenterol 98 (2003) 771-776